Effects of tiotropium on lung volumes during exercise in GOLD stage II to IV COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 171s Year: 2006
Effect of biologic lung volume reduction (BLVR) therapy on BODE at 6 and 12 weeks Source: Annual Congress 2008 - COPD Year: 2008
Predicted versus observed postoperative lung function six months after lung resection: A comparation between patients with and without COPD Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions Year: 2019
Polymeric lung volume reduction (PLVR) therapy for advanced homogeneous emphysema Source: Annual Congress 2010 - New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy Year: 2010
Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
Early versus late pulmonary rehabilitation (PR) following treatment for inoperable nonsmall cell lung cancer (NSCLC) Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013
Use of Bode index (BI) in patients with COPD undergoing inpatient pulmonary rehabilitation (IPR) after lung resection (LR) for non small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 70s Year: 2006
Effects of a combination of pulmonary rehabilitation (PR) and non invasive ventilation (NIV) in patients with advanced interstitial lung disease (ILD) Source: Annual Congress 2009 - Noninvasive ventilation in chronic respiratory failure Year: 2009
A dose ranging study of the aeris polymeric lung volume reduction (PLVR) system in patients with advanced upper lobe predominant (ULP) emphysema Source: Annual Congress 2009 - Treatment beyond inhalers Year: 2009
Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003
Noninvasive ventilation (NIV) after lung resection (LR) to prevent respiratory complications (RCs) in COPD patients (pts) (POPVNI trial) Source: Annual Congress 2011 - Noninvasive ventilation in the acute setting: education, organisation, H1N1, paediatrics, weaning, diagnostic procedures and special considerations Year: 2011
A single center experience with lung volume reduction coil (LVR-coil) treatment of patients with advanced emphysema. Effectiveness and complications after 1 year Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016
Results of unilateral lung volume reduction surgery (LVRS) in eight patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 107s Year: 2006
Benefit of continued pirfenidone treatment following hospitalisation within the first 6 months of therapy—Ad hoc analysis from three phase 3 trials in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015
Effect of polymeric lung volume reduction (PLVR) therapy on composite COPD outcome measures Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010
6 and 12 month outcomes following RePneu bronchoscopic lung volume reduction coil treatment Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013
Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013
Fatigue in patients with idiopathic pulmonary fibrosis (IPF) from the pooled pirfenidone (PFD) Phase III trials Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017
Efficacy of next treatment received after Nivolumab (Nivo) progression in patients (pts) with non-small-cell lung cancer (NSCLC). Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017